Phase 1 of our clinical trials is about to begin[[[[ awaiting on confirmation of news ]]]] .
Toxicology,staff to manage phase 1 is all in place[[[awaiting on confirmation of news ]]]].
Animal testing of Emtinb has a big confirmation of this to be a very positive outcome.
Pharmaceutical companies will have this on number 1 watchlist.
Negotiations probably spoken about a possible takeover on the outcome of just phase 1.
Expecting a joint venture announcement on human trials.
All of this is just my opinion but it is the way i see the next 6 months heading, my conservative value is now much higher,but i will keep that to myself, all in all i feel this may be one of the top movers in the ASX this year.
NSB Price at posting:
31.0¢ Sentiment: Hold Disclosure: Held
